Inhibition of the mammalian target or rapamycin (mTOR): a potential therapeutic strategy for multiple system atrophy
Sirolimus
03 medical and health sciences
0302 clinical medicine
TOR Serine-Threonine Kinases
Animals
Humans
Multiple System Atrophy
Immunosuppressive Agents
DOI:
10.1007/s10286-019-00662-4
Publication Date:
2020-01-09T13:02:36Z
AUTHORS (2)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (14)
CITATIONS (4)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....